MX9307821A - NEW KIND OF PROTEASE ASPARTILE INHIBITORS. - Google Patents

NEW KIND OF PROTEASE ASPARTILE INHIBITORS.

Info

Publication number
MX9307821A
MX9307821A MX9307821A MX9307821A MX9307821A MX 9307821 A MX9307821 A MX 9307821A MX 9307821 A MX9307821 A MX 9307821A MX 9307821 A MX9307821 A MX 9307821A MX 9307821 A MX9307821 A MX 9307821A
Authority
MX
Mexico
Prior art keywords
hiv
relates
aspartile
protease
inhibitors
Prior art date
Application number
MX9307821A
Other languages
Spanish (es)
Inventor
Joshua S Boger
Harold V Meyers
Michael D Mullican
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of MX9307821A publication Critical patent/MX9307821A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/04—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/21—Radicals derived from sulfur analogues of carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se relaciona con una nueva clase de compuestos inhibidores de la proteasa aspartilo. En una de sus modalidades, este invento se relaciona con una nueva clase de inhibidores de proteasa aspartilo de VIH, derivados del manitol, caracterizados por propiedades estructurales y fisicoquímicas específicas. Esta invención se refiere también a composiciones farmacéuticas que comprenden estos compuestos. Los compuestos y las composiciones farmacéuticas de la presente invención son particularmente adecuados para inhibir la actividad de la proteasa aspartilo de VIH. Por consiguiente, pueden usarse de manera provechosa como agentes antivirales contra los virus VIH, con inclusión de los virus VIH-1 y VIH-2.The present invention relates to a new class of aspartyl protease inhibitor compounds. In one of its embodiments, this invention relates to a new class of mannitol-derived HIV aspartyl protease inhibitors characterized by specific structural and physicochemical properties. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of the present invention are particularly suitable for inhibiting the activity of HIV aspartyl protease. Accordingly, they can be usefully used as antiviral agents against HIV viruses, including HIV-1 and HIV-2 viruses.

MX9307821A 1992-12-11 1993-12-10 NEW KIND OF PROTEASE ASPARTILE INHIBITORS. MX9307821A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98923992A 1992-12-11 1992-12-11

Publications (1)

Publication Number Publication Date
MX9307821A true MX9307821A (en) 1994-06-30

Family

ID=25534900

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9307821A MX9307821A (en) 1992-12-11 1993-12-10 NEW KIND OF PROTEASE ASPARTILE INHIBITORS.

Country Status (6)

Country Link
CN (1) CN1094055A (en)
AU (1) AU5748194A (en)
IL (1) IL107978A0 (en)
MX (1) MX9307821A (en)
WO (1) WO1994013629A1 (en)
ZA (1) ZA939285B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798355A (en) * 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5646180A (en) * 1995-12-05 1997-07-08 Vertex Pharmaceuticals Incorporated Treatment of the CNS effects of HIV
MY126358A (en) * 1996-03-22 2006-09-29 Glaxo Group Ltd Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs
US6218424B1 (en) 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
SE9701245D0 (en) 1997-04-04 1997-04-04 Bjoern Classon antivirals
US6271244B1 (en) 1998-06-03 2001-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
US6187784B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6274602B1 (en) 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6187796B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Sulfone hair growth compositions and uses
US6172087B1 (en) 1998-06-03 2001-01-09 Gpi Nil Holding, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
CA2334204A1 (en) 1998-06-03 1999-12-09 Gpi Nil Holdings, Inc. Heterocyclic ester and amide hair growth compositions and uses
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6376517B1 (en) 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
US6399648B1 (en) 1998-08-14 2002-06-04 Gpi Nil Holdings, Inc. N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6335348B1 (en) 1998-08-14 2002-01-01 Gpi Nil Holdings, Inc. Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
US6506788B1 (en) 1998-08-14 2003-01-14 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
US6339101B1 (en) 1998-08-14 2002-01-15 Gpi Nil Holdings, Inc. N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
US6337340B1 (en) 1998-08-14 2002-01-08 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6384056B1 (en) 1998-08-14 2002-05-07 Gpi Nil Holdings, Inc. Heterocyclic thioesters or ketones for vision and memory disorders
US6333340B1 (en) 1998-08-14 2001-12-25 Gpi Nil Holdings, Inc. Small molecule sulfonamides for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6362165B1 (en) 1999-03-30 2002-03-26 Pharmacor Inc. Hydroxyphenyl derivatives with HIV integrase inhibitory properties
US6313177B1 (en) * 1999-04-30 2001-11-06 Pharmacor Inc. D-mannitol derivatives as HIV aspartyl protease inhibitors
CN102731350B (en) * 2012-07-05 2014-04-16 浙江大学 Sulfhydryl compound containing beta-ester groups and acetyl-transferred synthesis method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3239858A1 (en) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen NEW D-MANNITE DERIVATIVES AS STARTING PRODUCTS FOR THE SYNTHESIS OF PHOSPHOLIPIDES
JPH06501681A (en) * 1990-07-06 1994-02-24 スミスクライン・ビーチャム・コーポレイション Inhibitors of retroviral proteases
AU1677092A (en) * 1991-03-20 1992-10-21 Vertex Pharmaceuticals Incorporated Tetrahydroxyalkane derivatives as inhibitors of hiv aspartyl protease

Also Published As

Publication number Publication date
ZA939285B (en) 1994-09-06
AU5748194A (en) 1994-07-04
IL107978A0 (en) 1994-04-12
CN1094055A (en) 1994-10-26
WO1994013629A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
MX9307821A (en) NEW KIND OF PROTEASE ASPARTILE INHIBITORS.
ES2131589T3 (en) HIV ASPARTIL-PROTEASE INHIBITOR SULFONAMIDES.
AR004663A1 (en) A PROTEASE ASPARTILE INHIBITOR COMPOUND, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND METHODS TO INHIBIT THE PROTEASE ACTIVITY ASPARTILE, TO REVERSIBLY ADHERE PROTEASE ASPARTILE AND TO AVOID OR TREAT HIV INFECTIONS WITH SUCH COMPOUND
AR031520A1 (en) AN INHIBITOR COMPOSITE OF ASPARTILO PROTEASA, A COMPOSITION THAT INCLUDES IT AND A METHOD TO TREAT A PATIENT WITH SUCH COMPOSITION
ES2181882T3 (en) INHIBITOR SULFONAMIDS OF ASPARTILL-PROTEASA CONTAINING TETRAHYDROFURANE (THF).
MX9403380A (en) HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS.
MX9603909A (en) Sulphonamide derivatives as aspartyl protease inhibitors.
ES2181725T3 (en) HIV PROTEASA INHIBITORS.
ME00561B (en) Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
CO4940451A1 (en) DERIVATIVES OF BARBITURIC ACID WITH ANTIMETASTIC AND ANTITUMORAL ACTIVITY
ES2177868T3 (en) HYDROXYETHYLAMINOSULPHONAMIDS OF ALPHA- AND BETA-AMINO ACIDS AS INHIBITORS OF RETROVIRIC PROTEASES.
ES2157437T3 (en) INHIBITORS OF RETROVIRAL PROTEASES OF SULFONILALCANOILAMINO-HIDROXIETILAMINO-SULFONAMIDA.
ES2107609T3 (en) SYNTHETIC POLYPEPTIDES AS HIV-1 INHIBITORS.
ES2150933T3 (en) HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS.
GT200100201A (en) DERIVATIVES OF PIRAZOL FOR THE TREATMENT DER VIRIC DISEASES.
ES2183817T3 (en) METAZOAR PARASATIS PROTEASES INIBIDORS.
ES2101252T3 (en) HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS.
ES2174921T3 (en) HIV PROTEASE INHIBITORS.
AR009935A1 (en) AN EFFECTIVE COMPOUND TO INHIBIT ASPARTILPROTEASE, COMPOSITIONS THAT INCORPORATE IT AND METHODS TO PREVENT OR TREAT HIV INFECTIONS
CO4130200A1 (en) HELPFUL HIV PROTEASE INHIBITORS IN AIDS TREATMENT
MX9206563A (en) USE OF AMPHOTERICIN B DERIVATIVES AS PROTEASE INHIBITORS.
BR112018015629A2 (en) "compound, composition, method for treating a mammal infected with hiv virus, and triple mutant protein"
ES2103577T3 (en) ANTIVIRIC COMPOUNDS OF NAFTOQUINONE, COMPOSITIONS CONTAINING THEM AND USES OF THESE COMPOUNDS.
AR011586A1 (en) ANTIVIRAL AGENTS DERIVED FROM 6-BENCIL-1-ETOXIMETIL-5-URACILO SUBSTITUTED AND ITS USE FOR THE TREATMENT OF VIRAL INFECTIONS
AR013087A1 (en) FORM V OF AMPRENAVIR, ITS USE AS ANTIVIRAL COMPOUND, A PROCESS TO PREPARE IT, AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND IT